A Phase I/II Study of XZP-3287 in Metastasis Solid Tumors

NCT04539496 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

402

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastasis Solid Tumors
Advanced Breast Cancer

Interventions

DRUG: XZP-3287
DRUG: XZP-3287;Letrozole;Anastrozole;Fulvestrant
DRUG: XZP-3287

Sponsor

Sihuan Pharmaceutical Holdings Group Ltd.